BusinessIndia Globalization Capital Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)By Nasdaq OMXMar 12, 2018, 12:01 PM UTC
BusinessIGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization StageBy Nasdaq OMXFeb 20, 2018, 2:14 PM UTC
BusinessIndia Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13By Nasdaq OMXFeb 12, 2018, 1:02 PM UTC
BusinessIGC Prepares a Liquid Delivery Formulation of IGC-AD1 for Alzheimer’s Based on Novel In Vitro DataBy Nasdaq OMXOct 4, 2017, 12:00 PM UTC
BusinessIGC Announces Financial Results for Fiscal Year Ended March 31, 2017By Nasdaq OMXJul 14, 2017, 6:00 AM UTC
BusinessIGC Files International Patents for IGC-501 Compound Indicated for Neuropathic PainBy Nasdaq OMXApr 10, 2017, 10:00 AM UTC
BusinessIGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504By Nasdaq OMXFeb 13, 2017, 11:01 AM UTC
